{
  "cui": "C1335661",
  "cui_name": "Radiation-Related Angiosarcoma",
  "incidence_per_100k": 0.05,
  "prevalence_per_100k": null,
  "metric_type": "incidence",
  "total_cases_per_year": 4000,
  "confidence": 0.62,
  "is_subtype": true,
  "parent_disease": "Angiosarcoma",
  "reasoning": "Radiation-induced angiosarcoma (RIAS) is a rare secondary malignancy following radiotherapy, most commonly after breast cancer treatment. Occurs in 0.05-0.3% of breast cancer patients receiving breast-conserving surgery and adjuvant radiotherapy. Conservative global estimate of 0.05 per 100,000 based on cumulative incidence studies. Median latency period is 6 years (range 3-12 years).",
  "data_quality": "moderate",
  "geographic_variation": "moderate",
  "year_specific": false,
  "data_year": 2005,
  "source": "Pitson G et al. (2005). Radiation-associated sarcoma after breast cancer. Int J Radiat Oncol Biol Phys. 62(2):307-315",
  "source_url": null,
  "source_type": "literature"
}
